Gene therapy may be ‘one-shot stop’ for rare bone disease

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three to six times each week.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup